Spegra - Dolutegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg 30 Tablets - Antiretroviral Medication

Spegra – Dolutegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg x 30 Tablets

$260.00 $110.00
image Prescription Required

Spegra Tablet is a once-daily antiretroviral medication used to treat HIV-1 infection in adults. It combines three powerful ingredients Dolutegravir (50mg) + Emtricitabine (200mg) + Tenofovir Alafenamide (25mg) to effectively suppress the HIV virus, reduce its ability to multiply, and strengthen the immune system.

Generic Name Dolutegravir (50mg) + Emtricitabine (200mg) + Tenofovir Alafenamide (25mg)
Manufacturer Emcure Pharmaceuticals Ltd
Packing 30 Tablets in 1 Bottle
Prescribed For HIV-1 Infection
Availability In Stock

Contact us on WhatsApp

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Benefits of Spegra Tablet

  • Controls HIV infection effectively
  • Boosts immune system strength
  • Reduces viral load quickly
  • Convenient once-daily dosage

Side Effects

  • Headache
  • Nausea
  • Diarrhea
  • Insomnia (trouble sleeping)
  • Tiredness or fatigue
  • Abdominal discomfort
  • Weight gain

Get Spegra – Dolutegravir 50mg + Emtricitabine 200mg + Tenofovir Alafenamide 25mg Tablets in Bulk at Wholesale Prices from Our Generic Pharmacy

As a fully licensed supplier of high-quality generic antiretroviral medicines, we provide Spegra – Dolutegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg Tablets, commonly used for the treatment of HIV‑1 infection in adults and adolescents.

We ensure safe, consistent, and timely bulk supply of generic HIV drugs to hospitals, clinics, pharmacies, healthcare providers, physicians, NGOs, and authorized buyers in over 80 countries worldwide. Our distribution network spans Latin America, Africa, Asia, Europe, the Middle East, and North America, covering regions such as Mexico, Brazil, Colombia, Peru, Chile, UAE, Saudi Arabia, Egypt, South Africa, Namibia, Kenya, Nigeria, Singapore, Vietnam, Thailand, the Philippines, Canada, and many more.

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.

Need assistance? Chat with us